Key takeaways:
- Healio AI will integrate fundamentals of the Cincinnati Protocol into its core knowledge base.
- The partnership furthers Healio AI’s objective of providing verified information for physicians.
Healio AI announced an official partnership with The Holland Foundation for Sight Restoration, which is dedicated to helping those with severe ocular surface disease.
“Staying current with the most up to date medical opinions and treatment strategies is at the essence of what it means to be a physician and use best practices to treat patients,” Stephen S. Lane, MD, chair of the board of directors for The Holland Foundation for Sight Restoration (HFSR), said in a press release from The Wyanoke Group. “Today we have wonderful tools at our fingertips to gain these insights with trusted sources of knowledge. I am happy that HFSR has partnered with Healio AI to leverage its trusted corpus of knowledge to eliminate barriers to physicians accessing the most current and comprehensive content whenever and wherever they need it.”
Healio AI will now integrate educational content from HFSR.
According to the release, Healio AI will now integrate educational content from HFSR, a 501(c)(3) nonprofit organization, into its core knowledge base, including the fundamentals of the Cincinnati Protocol for stem cell transplantation in patients with severe ocular surface disease. HFSR, which was founded by ophthalmologist Edward J. Holland, MD, will help further Healio AI’s objective of providing trusted, verified AI sources for physicians.
“Bringing a one-of-kind source to a one-of-a-kind platform is a powerful step forward for trusted clinical AI,” Joan-Marie Stiglich, ELS, Chief AI Officer at Healio, said in the release. “In a time when trust matters more than ever, this partnership strengthens our commitment to delivering authoritative, reliable answers backed by the industry’s most respected content.”
Ask a clinical question and tap into Healio AI’s knowledge base.
- PubMed, enrolling/recruiting trials, guidelines
- Clinical Guidance, Healio CME, FDA news
- Healio’s exclusive daily news coverage of clinical data
